Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Alveolar barrier disruption in varicella pneumonia is associated with neutrophil extracellular trap formation
Werner J.D. Ouwendijk, Henk-Jan van den Ham, Mark W. Delany, Jeroen J.A. van Kampen, Gijsbert P. van Nierop, Tamana Mehraban, Fatiha Zaaraoui-Boutahar, Wilfred F.J. van IJcken, Judith M.A. van den Brand, Rory D. de Vries, Arno C. Andeweg, Georges M.G.M. Verjans
Werner J.D. Ouwendijk, Henk-Jan van den Ham, Mark W. Delany, Jeroen J.A. van Kampen, Gijsbert P. van Nierop, Tamana Mehraban, Fatiha Zaaraoui-Boutahar, Wilfred F.J. van IJcken, Judith M.A. van den Brand, Rory D. de Vries, Arno C. Andeweg, Georges M.G.M. Verjans
View: Text | PDF
Research Article Pulmonology Virology

Alveolar barrier disruption in varicella pneumonia is associated with neutrophil extracellular trap formation

  • Text
  • PDF
Abstract

Primary varicella-zoster virus (VZV) infection in adults is often complicated by severe pneumonia, which is difficult to treat and is associated with high morbidity and mortality. Here, the simian varicella virus (SVV) nonhuman primate (NHP) model was used to investigate the pathogenesis of varicella pneumonia. SVV infection resulted in transient fever, viremia, and robust virus replication in alveolar pneumocytes and bronchus-associated lymphoid tissue. Clearance of infectious virus from lungs coincided with robust innate immune responses, leading to recruitment of inflammatory cells, mainly neutrophils and lymphocytes, and finally severe acute lung injury. SVV infection caused neutrophil activation and formation of neutrophil extracellular traps (NETs) in vitro and in vivo. Notably, NETs were also detected in lung and blood specimens of varicella pneumonia patients. Lung pathology in the SVV NHP model was associated with dysregulated expression of alveolar epithelial cell tight junction proteins (claudin-2, claudin-10, and claudin-18) and alveolar endothelial adherens junction protein VE-cadherin. Importantly, factors released by activated neutrophils, including NETs, were sufficient to reduce claudin-18 and VE-cadherin expression in NHP lung slice cultures. Collectively, the data indicate that alveolar barrier disruption in varicella pneumonia is associated with NET formation.

Authors

Werner J.D. Ouwendijk, Henk-Jan van den Ham, Mark W. Delany, Jeroen J.A. van Kampen, Gijsbert P. van Nierop, Tamana Mehraban, Fatiha Zaaraoui-Boutahar, Wilfred F.J. van IJcken, Judith M.A. van den Brand, Rory D. de Vries, Arno C. Andeweg, Georges M.G.M. Verjans

×

Figure 7

Detection of NETs in patients with severe varicella pneumonia and influenza pneumonia.

Options: View larger image (or click on image) Download as PowerPoint
Detection of NETs in patients with severe varicella pneumonia and influe...
(A and B) Detection of His-DNA (A) and MPO-DNA complexes (B) in paired BAL and blood samples (obtained ± 2 days of BAL sample) in human influenza and VZV pneumonia patients by ELISA. Squares and circles indicate plasma and serum samples, respectively. Dashed line indicates absorbance in serum of healthy human control subjects. (C) Correlation between His-DNA (circles) and MPO-DNA (squares) complexes in BAL (red), paired plasma/serum samples (light gray), and time from onset of disease in VZV pneumonia. Filled arrowhead indicates time of hospital discharge (patient 1); open arrowhead indicates time of death (patient 2); arrow indicates time of secondary bacterial infection of the lung (patient 3). (A–C) The y axis indicates absorbance at 450–620 nm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts